Accordingly, this study was conducted to assess the application value of serum TK1, PCDGF, CYFRA21-1, NSE, and CEA plus enhanced CT scan in the diagnosis of NSCLC and chemotherapy monitoring. This evidence concerns the gene TK1 and non-small cell lung carcinoma.